本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

157.20
-4.3200-2.67%
盤前163.516.31+4.01%08:56 EDT
成交量:28.71萬
成交額:4,532.36萬
市值:94.91億
市盈率:-24.98
高:165.26
開:161.78
低:156.28
收:161.52
資料載入中...
2019/10/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]